- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Amgen Inc+ Add to Watchlist
AMGN:US167.9100 USD 1.2600 0.74%
As of 20:10:00 ET on 04/24/2015.
Company Profile for Amgen Inc (AMGN)
Amgen Inc. is an independent biotechnology medicines company that discovers, develops, manufactures and markets medicines for grievous illnesses. The Company focuses solely on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology.
Key Executives for Amgen Inc (AMGN)
|Robert A Bradway "Bob"Chairman/President/CEO||Annette L SuchChief Accounting Officer|
|David W MelineExec VP/CFO||Anthony C Hooper "Tony"Exec VP:Global Commercial Ops|
|Brian M McNameeExec VP:Full Potential||Madhavan Balachandran "Madhu"Exec VP:Operations|
|Sean E HarperExec VP:Research & Dev||David J ScottSenior VP/Secy/General Counsel|
|Mary A LehmannVP:Finance & Treasurer||Arvind SoodVP:Investor Relations|